Trial Profile
Ridaforolimus pharmacokinetics in fed or fasting subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Aug 2012
Price :
$35
*
At a glance
- Drugs Ridaforolimus (Primary)
- Indications Breast cancer; Cancer; Endometrial cancer; Neurodegenerative disorders; Non-small cell lung cancer; Prostate cancer; Sarcoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Merck & Co
- 12 Mar 2011 New trial record